Nurse Practitioner, Family · Saint George, UT
NPI
1649936535
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
368 E Riverside Dr Ste A
Saint George, UT, 84790
Phone (435) 673-1149
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
974 services
Medicare patients, 2024
425
Average age 75
Drug cost, 2024
$1.5M
1,652 prescriptions
Company payments, 2025
$2,562
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nekenzie Jones was code 99214 (office e&m - established), 564 times for 295 patients. In total Nekenzie Jones billed 974 services in 15 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 564 | 295 | $72.88 | $41K |
| 99213 Office E&M - Established | Office | 130 | 118 | $53.05 | $6,896 |
| 99204 Office E&M - New | Office | 103 | 103 | $84.17 | $8,670 |
| 99212 Office E&M - Established | Office | 55 | 49 | $32.85 | $1,807 |
| 46221 Digestive/Gastrointestinal | Office | 44 | 22 | $164.95 | $7,258 |
| 46600 Digestive/Gastrointestinal | Office | 32 | 31 | $69.34 | $2,219 |
| 99215 Office E&M - Established | Office | 17 | 15 | $116.22 | $1,976 |
By year: 2022 $39K for 464 services; 2023 $72K for 941 services; 2024 $74K for 974 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nekenzie Jones prescribed most often to Medicare patients was Omeprazole, with 270 prescriptions and refills. In total Nekenzie Jones wrote 1,652 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 270 | 691 | 126 | $5,266 |
| Famotidine Generic | 266 | 571 | 95 | $3,987 |
| Pantoprazole Sodium Generic | 224 | 538 | 98 | $3,768 |
| Dicyclomine Hcl Generic | 90 | 112 | 31 | $3,204 |
| Sucralfate Generic | 81 | 93 | 48 | $2,898 |
| Mesalamine Generic | 45 | 98 | 13 | $21K |
| Ondansetron Odt Ondansetron | 45 | 45 | 25 | $1,384 |
| Creon Lipase/Protease/Amylase | 43 | 52 | 14 | $151K |
| Azathioprine Generic | 39 | 89 | 13 | $1,009 |
| Cholestyramine Light Cholestyramine | 35 | 45 | 23 | $5,090 |
| Sucraid Sacrosidase | 35 | 35 | Under 11 | $484K |
| Colestipol Hcl Generic | 32 | 81 | 15 | $3,344 |
| Ursodiol Generic | 30 | 46 | Under 11 | $2,907 |
| Linzess Linaclotide | 26 | 44 | Under 11 | $23K |
| Budesonide Dr Budesonide | 25 | 47 | 17 | $6,752 |
Brand drugs: - claims; generic drugs: 1,420 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nekenzie Jones $2,562 ($2,562 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $598.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 30 | $598 |
| Janssen Biotech, Inc. JNJ | 16 | $378 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $260 |
| Ardelyx, Inc. ARDX | 9 | $247 |
| Madrigal Pharmaceuticals MDGL | 9 | $241 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $205 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $136 |
| Lilly USA, LLC LLY | 3 | $93.23 |
| Intercept Pharmaceuticals, Inc. | 4 | $70.46 |
| Gilead Sciences, Inc. GILD | 4 | $66.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.